Sakura Finetek USA
Layla Hiramatsu, PhD, is a Lead Scientific Technical Writer at Sakura Finetek USA, specializing in regulatory and technical documentation for medical devices and possessing expertise in Quality Management Systems and in-vitro diagnostic regulations. Previously, as a Bioinformatics Postdoc at the Friedrich Miescher Laboratory of the Max Planck Society, Layla analyzed short-term evolution using next-generation DNA sequencing and co-authored a research manuscript. Layla's academic background includes a PhD in Evolutionary Physiology from the University of California, Riverside, where significant achievements included optimizing data analysis workflows and publishing multiple peer-reviewed articles. Additionally, Layla earned an "Outstanding Teaching Award" as a Graduate Teaching Assistant while also developing educational materials on evolutionary theory.
Sakura Finetek USA
At Sakura Finetek, we are committed to advancing cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care. We have become a name trusted and respected group by customers in hospitals and laboratories worldwide and globally provide smartly automated histopathology systems and services. From grossing to slide imaging and every step in between, we are leading the industry in product quality and reliability. Sakura Finetek is committed to these core values: Providing excellence in customer satisfaction Placing an emphasis on teamwork worldwide Fostering a positive, diverse and safe work environment Continuously improving quality and reliability of our products Focusing on innovative systems and laboratory automation in product design If you require technical support we invite you to contact us at 800-725-8723, Option 2 or mail@sakuraus.com MSOC0007 Rev.A